Australian Pharmaceutical Industries on Monday said it had signed an agreement with Wesfarmers Ltd for the retail conglomerate to buy all of its shares in a deal valuing the pharmacy chain at A$763.6 million ($564.9 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
